MRNA

Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief…

Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due…

Moderna Inc (NASDAQ:MRNA) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief…

Moderna, Inc (NASDAQ: MRNA) Q3 2022 Earnings Conference

Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head…

Moderna Inc.  (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head…

Moderna, Inc (NASDAQ: MRNA) Q1 2022 Earnings Conference

Moderna, Inc. (NASDAQ: MRNA) Q4 2021 earnings call dated Feb. 24, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President & Head of…

Moderna, Inc (NASDAQ: MRNA) Q3 2021 Earnings Conference

Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of…